Advertisement

Endocrine

, Volume 63, Issue 1, pp 140–148 | Cite as

Alterations in hypothalamic-pituitary-adrenal function immediately after resection of adrenal adenomas in patients with Cushing’s syndrome and others with incidentalomas and subclinical hypercortisolism

  • Dena Khawandanah
  • Nadine ElAsmar
  • Baha M ArafahEmail author
Endocrine Surgery
  • 62 Downloads

Abstract

Background

Patients with cortisol secreting adrenal adenomas present with Cushing’s syndrome (CS), while 5–15% of subjects with adrenal incidentalomas have subclinical hypercortisolism (SH) as they have biochemical abnormalities suggesting autonomous cortisol secretion without associated clinical features of CS.

Goals

Examine HPA function immediately after resection of either of these adenomas and utilize the data to decide on initiating glucocorticoid replacement.

Methods

ACTH, cortisol, and DHEA-S levels were measured frequently for 8 h after adrenalectomy in 14 patients with CS and 19 others with incidentalomas + SH. Glucocorticoids were withheld before/during surgery and administered 6–8 h postoperatively to those who had cortisol levels of <3 ug/dL (83 nmol/L).

Results

Preoperatively, incidentalomas + SH patients had larger tumors, higher ACTH, and DHEA-S but lower dexamethasone-suppressed serum cortisol levels than those with CS. Postoperatively, ACTH levels increased in both groups: (90.1 ± 31.6; 24.1 ± 14.4 ng/L, respectively; P < 0.001). Postoperative ACTH levels correlated negatively with preoperative Dexamethasone-suppressed cortisol concentrations in both groups. Patients with CS had steeper decline in cortisol concentrations than those with incidentalomas + SH. All patients with CS had hypocortisolemia requiring glucocorticoid therapy for several months, while only 5/19 with incidentalomas + SH had cortisol levels <3 ug/dL;(83 nmol/L) 6–8 h after adrenalectomy and received hydrocortisone replacement therapy for ≤4 weeks.

Conclusions

Surgical stress stimulates HPA function even in patients with hypercortisolemia. Patients with incidentalomas + SH have incomplete HPA suppression that allows more robust response to surgical stress than that observed in patients with CS. HPA assessment immediately after surgical resection of adrenal incidentalomas identified those requiring glucocorticoid replacement before discharge.

Keywords

HPA ACTH Cortisol-secreting Adenomas Adrenal incidentalomas Adrenalectomy 

Notes

Funding

Local/departmental

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the Institutional Review Board and with the 1964 Helsinki declaration and later amendments or comparable ethical standards.

Informed consent

An informed consent was obtained from all participants in the study.

References

  1. 1.
    M. Reincke, Subclinical Cushing’s syndrome. Endocrinol. Metab. Clin. North Am. 29(1), 43–56 (2000)CrossRefGoogle Scholar
  2. 2.
    M. Terzolo, G. Reimondo, S. Bovio, A. Angeli, Subclinical Cushing’s syndrome. Pituitary 7(4), 217–223 (2004)CrossRefGoogle Scholar
  3. 3.
    V. Morelli, B. Masserini, A.S. Salcuni, C. Eller-Vainicher, C. Savoca, R. Viti, F. Coletti, G. Guglielmi, C. Battista, L. Lorio, P. Beck-Peccoz, B. Ambrosi, M. Arosio, A. Scillitani, I. Chiodini, Subclinical hypercortisolism: correlation between biochemical diagnostic criteria and clinical aspects. Clin. Endocrinol. 73(2), 161–166 (2010)Google Scholar
  4. 4.
    I. Chiodini, Clinical review: diagnosis and treatment of subclinical hypercortisolism. J. Clin. Endocrinol. Metab. 96(5), 1223–1236 (2011)CrossRefGoogle Scholar
  5. 5.
    M. Terzolo, A. Pia, G. Reimondo, Subclinical Cushing’s syndrome: definition and management. Clin. Endocrinol. 76(1), 12–18 (2012)CrossRefGoogle Scholar
  6. 6.
    L.K. Neiman, Update on subclinical Cushing’s syndrome. Curr. Opin. Endocrinol. Diabetes Obese 22(3), 180–184 (2015)CrossRefGoogle Scholar
  7. 7.
    M. Terzolo, A. Pia, A. Alì, G. Osella, G. Reimondo, S. Bovio, F. Daffara, M. Procopio, P. Paccotti, G. Borretta, A. Angeli, Adrenal incidentaloma: a new cause of the metabolic syndrome? J. Clin. Endocrinol. Metab. 87(3), 998–1003 (2002)CrossRefGoogle Scholar
  8. 8.
    I. Chiodini, V. Morelli, B. Masserini, A.S. Salcuni, C. Eller-Vainicher, R. Viti, F. Coletti, G. Guglielmi, C. Battista, V. Carnevale, L. Iorio, P. Beck-Peccoz, M. Arosio, B. Ambrosi, A. Scillitani, Bone mineral density, prevalence of vertebral fractures and bone quality in patients with adrenal incidentalomas with and without subclinical hypercortisolism: an Italian Multicenter Study. J. Clin. Endocrinol. Metab. 94(9), 3207–3214 (2009)CrossRefGoogle Scholar
  9. 9.
    C. Eller-Vainicher, V. Morelli, F.M. Uliveri, S. Palmieri, V.V. Zhukouskaya, E. Cairoli, R. Pino, A. Naccarato, A. Scillitani, P. Beck-Peccoz, I. Chiodini, Bone quality, as measured by trabecular bone score in patients with adrenal incidentalomas with and without subclinical hypercortisolism. J. Bone Miner. Res. 27(10), 2223–2230 (2012)Google Scholar
  10. 10.
    V. Morelli, C. Eller-Vainicher, A.S. Salcuni, F. Coletti, L. Iorio, G. Muscogiuri, S. Della Casa, M. Arosio, B. Ambrosi, P. Beck-peccoz, I. Chiodini, Risk of new vertebral fractures in patients with adrenal incidentaloma with and without subclinical hypercortisolism: a multicenter longitudinal study. J. Bone Miner. Res. 26(8), 1816–1821 (2011)CrossRefGoogle Scholar
  11. 11.
    L. Tauchmanovà, R. Rossi, B. Biondi, M. Pulcrano, V. Nuzzo, E.A. Palmieri, S. Fazio, G. Lombardi, Patients with subclinical Cushing’s syndrome due to adrenal adenoma have increased cardiovascular risk. J. Clin. Endocrinol. Metab. 87(11), 4872–4878 (2002)CrossRefGoogle Scholar
  12. 12.
    V. Morelli, G. Reimondo, Giordano, S. Della Casa, C. Policola, S. Palmieri, A.S. Salcuni, A. Dolci, M. Mendola, M. Arosio, B. Ambrosi, A. Scillitani, E. Ghigo, P. Beck-Peccoz, M. Terzolo, I. Chiodini, Long-term follow-up in adrenal incidentalomas: an Italian multicenter study. J. Clin. Endocrinol. Metab. 99(3), 827–834 (2014)CrossRefGoogle Scholar
  13. 13.
    I. Chiodini, V. Morelli, A.S. Salcuni, C. Eller-Vainicher, M. Torlontano, F. Coletti, L. Iorio, A. Cuttitta, A. Ambrosio, L. Vicentini, F. Pellegrini, M. Copetti, P. Beck-Peccoz, M. Arosio, B. Ambrosi, V. Trischitta, A. Scillitani, Beneficial metabolic effects of prompt surgical treatment in patients with an adrenal incidentaloma causing biochemical hypercortisolism. J. Clin. Endocrinol. Metab. 95(6), 2736–2745 (2010)CrossRefGoogle Scholar
  14. 14.
    M. Iacobone, M. Citton, M. Scarpa, G. Viel, M. Boscaro, D. Nitti, Systematic review of surgical treatment of subclinical Cushing’s syndrome. Br. J. Surg. 102(4), 318–330 (2015)CrossRefGoogle Scholar
  15. 15.
    I. Akaza, T. Yoshimoto, F. Iwashima, C. Nakayama, M. Doi, H. Izumiyama, Y. Hirata, Clinical outcome of subclinical Cushing’s syndrome after surgical and conservative treatment. Hypertens. Res. 34(1), 1111–1115 (2011)CrossRefGoogle Scholar
  16. 16.
    I. Bancos, F. Alahdab, R.K. Crowley, V. Chortis, D.A. Delivanis, D. Erickson, N. Natt, M. Terzolo, W. Arlt, W.F.J.R. Young, M.H. Murad, Improvement of cardiovascular risk factors after adrenalectomy in patients with adrenal tumors and subclinical Cushing’s syndrome: A systematic review and meta-Analysis. Eur. J. Endocrinol. 175(6), R283–R295 (2016)CrossRefGoogle Scholar
  17. 17.
    M. Iacobone, M. Citton, G. Viel, R. Boetto, I. Bonadio, I. Mondi, S. Tropea, D. Nitti, G. Favia, Adrenalectomy may improve cardiovascular and metabolic impairment and ameliorate quality of life in patients with adrenal incidentalomas and subclinical Cushing’s syndrome. Surgery 152(6), 991–997 (2012)CrossRefGoogle Scholar
  18. 18.
    M.C. Dennedy, A.K. Annmalai, O. Prankerd-Smith, N. Freeman, K. Vengopal, J. Graggaber, O. Koulouri, A.S. Powlson, A. Shaw, D.J. Halsall, M. Gunnell, Low DHEA-S: A sensitive and specific test for the detection of subclinical hypercortisolism in adrenal incidentalomas. J. Clin. Endocrinol. Metab. 102, 786–792 (2017)Google Scholar
  19. 19.
    C. Eller-Vainicher, V. Morelli, A.S. Salcuni, M. Torlontano, F. Coletti, L. Iorio, A. Cuttitta, A. Ambrosio, L. Vicentini, V. Carnevale, P. Beck-Peccoz, M. Arosio, B. Ambrosi, A. Scillitani, I. Chiodini, Post-surgical hypocortisolism after removal of an adrenal incidentaloma: is it predictable by an accurate endocrinological work-up before surgery? Eur. J. Endocrinol. 162(1), 91–99 (2010)CrossRefGoogle Scholar
  20. 20.
    G. Di Dalmazi, C.M. Berr, M. Fassnacht, F. Beuschlein, M. Reincke, Adrenal function after adrenalectomy for subclinical hypercortisolism and Cushing’s syndrome: A systematic review of the literature. J. Clin. Endocrinol. Metab. 99, 2637–2645 (2014)CrossRefGoogle Scholar
  21. 21.
    C.M. Berr, G. Di Dalmazi, A. Osswald, K. Ritzel, M. Bidlingmaier, L.L. Geyer, M. Treitl, K. Hallfeldt, W. Rachinger, N. Reisch, R. Blaser, J. Schopohl, F. Beuschlein, M. Reincke, Time to recovery of adrenal function after curative surgery for Cushing’s syndrome depends on etiology. J. Clin. Endocrinol. Metab. 100(4), 1300–1308 (2015)CrossRefGoogle Scholar
  22. 22.
    M. Fassnacht, W. Arlt, I. Bancos, H. Dralle, J. Newell-Price, A. Sahdev, A. Tabarin, M. Terzolo, S. Tsagarakis, O.M. Dekkers, Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors. Eur. J. Endocrinol. 175(2), G1–G34 (2016)CrossRefGoogle Scholar
  23. 23.
    S.H. Lee, K.H. Song, J. Kim, S. Park, S.H. Ahn, H. Kim, Y.Y. Cho, S. Suh, B.J. Kin, J.H. Kim, J.M. Koh, New diagnostic criteria for subclinical hypercortisolism using postsurgical hypocortisolism: the co-work of adrenal research study. Clin. Endocrinol. 86(1), 10–18 (2017)CrossRefGoogle Scholar
  24. 24.
    V. Morelli, L. Minelli, C. Eller-Vainicher, S. Palmieri, E. Cairoli, A. Spada, M. Arosio, I. Chiodini, Predictability of hypoadrenalism occurrence and duration after adrenalectomy for ACTH independent hypercortisolism. J. Endocrinol. Invest. 41(4), 485–493 (2018)CrossRefGoogle Scholar
  25. 25.
    D. Ortiz, J.W. Finding, T.B. Carroll, B.R. Javorsky, A.A. Carr, D.B. Evans, T.W. Yen, T.S. Wang, Cosyntropin stimulation testing on postoperative day 1 allows for selective glucocorticoid replacement therapy after adrenalectomy for hypercortisolism: Results of a novel, multidisciplinary institutional protocol. Surgery 159(1), 259–265 (2016)CrossRefGoogle Scholar
  26. 26.
    B.M. Arafah, O.H. Pearson. in Cushing’s syndrome. ed. by R.E. Rakel. Conn’s Current Therapy, 36th edn., (WB Saunders Co, Philadelphia, 1984), p. 472–477Google Scholar
  27. 27.
    A. Krikorian, D. Abdelmannan, W.R. Selman, B.M. Arafah, Cushing disease: use of perioperative serum cortisol measurements in early determination of success following pituitary surgery. Neurosurg. Focus 23(3), E6–E11 (2007)CrossRefGoogle Scholar
  28. 28.
    D. Abdelmannan, W.R. Selman, B.M. Arafah, Perioperative management of Cushing’s disease. Rev. Endocr. Metab. Disord. 11, 127–134 (2010)CrossRefGoogle Scholar
  29. 29.
    D. Abdelmannan, J. Chaiban, W.R. Selman, B.M. Arafah, Recurrences of ACTH-secreting adenomas after pituitary adenomectomy can be accurately predicted by perioperative measurements of plasma ACTH levels. J. Clin. Endocrinol. Metab. 98(4), 1458–1465 (2013)CrossRefGoogle Scholar
  30. 30.
    N. El Asmar, A. Rajpal, W.R. Selman, B.M. Arafah, The value of perioperative levels of ACTH, DHEA, and DHEAS and tumor size in predicting recurrence of Cushing disease. J. Clin. Endocrinol. Metab. 103(2), 477–485 (2018)CrossRefGoogle Scholar
  31. 31.
    V. Bansal, N. El Asmar, W.R. Selman, B.M. Arafah, Pitfalls in the diagnosis and management of Cushing’s syndrome. Neurological. Focus 38, 1–11 (2015)Google Scholar
  32. 32.
    H. Derendorf, H. Mollmann, J. Barth, C. Mollmann, S. Tunn, M. Kreig, Pharmacokinetics and oral bioavailability of hydrocortisone. J. Clin. Pharmacol. 31, 473–476 (1991)CrossRefGoogle Scholar
  33. 33.
    B. Chernow, R. Alexander, R.C. Smallridge, E.R. Thompson, D. Cook, D. Beardsley, M.P. Fink, C.R. Lake, J.R. Fletcher, Hormonal responses to graded surgical stress. Arch. Intern. Med. 147, 1273–1278 (1987)CrossRefGoogle Scholar
  34. 34.
    R. Udelsman, J.A. Norton, S.E. Jelenich, D.S. Goldstein, W.M. Linehan, D.L. Loriaux, G.P. Chrousos, Responses of the hypothalamic-pituitary-adrenal and renin-angiotensin axes and the sympathetic system during controlled surgical and anesthetic stress. J. Clin. Endocrinol. Metab. 64, 986–994 (1987)CrossRefGoogle Scholar
  35. 35.
    K. El-Sibai, A. Rajpal, W.R. Selman, B.M. Arafah, The impact peri-operative dexamethasone administration on the normal hypothalamic pituitary adrenal response to major surgical procedures. Endocrine 58, 134–142 (2017)CrossRefGoogle Scholar
  36. 36.
    A.F. Cheres, N. ElAsmar, A. Rajpal, W.R. Selman, B.M. Arafah, Perioperative hypothalamic pituitary adrenal function in patients with silent corticotroph adenomas. Pituitary 20(4), 471–476 (2017)CrossRefGoogle Scholar
  37. 37.
    V. Morelli, L. Minelli, C. Eller-Vainicher, S. Palmieri, E. Cairoli, A. Spada, M. Arosio, I. Chiodini, Predictability of hypoadrenalism occurrence and duration after adrenalectomy for ACTH-independent hypercortisolism. J. Endocrinol. Investig. 41, 485–493 (2018)CrossRefGoogle Scholar
  38. 38.
    A. Prete, R.M. Paragliola, F. Bottiglieri, C.A. Rota, A. Pontecorvi, R. Salvatori, S.M. Corsello, Factors predicting the duration of adrenal insufficiency in patients successfully treated for Cushing’s disease an nonmalignant primary adrenal Cushing’s syndrome. Endocrine 55, 969–980 (2017)CrossRefGoogle Scholar
  39. 39.
    M. Reincke, J. Nieke, G.P. Krestin, W. Saeger, B. Allolio, W. Winkelmann, Precrinical Cushing’s syndrome in adrenal incidentalomas: comparison with adrenal Cushing’s syndrome. J. Clin. Endocrinol. Metab. 75, 826–832 (1992)Google Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • Dena Khawandanah
    • 1
  • Nadine ElAsmar
    • 1
  • Baha M Arafah
    • 1
    Email author
  1. 1.Division of Clinical and Molecular Endocrinology, UH-Cleveland Medical CenterCase Western Reserve UniversityClevelandUSA

Personalised recommendations